The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli

FEMS Immunology and Medical Microbiology

Volumn 59, Issue 3, 2010, Pages 447-455

  Carson, Louise ^a   Gorman, Sean P ^a   Gilmore, Brendan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

bacteriophage; biofilm; catheter; Escherichia coli; hydrogel; Proteus mirabilis

Indexed keywords

BIOMATERIAL;

ARTICLE; BACTERIOPHAGE; BALLOON CATHETER; BIOFILM; CONTROLLED STUDY; ERADICATION THERAPY; ESCHERICHIA COLI; HYDROGEL; IN VITRO STUDY; INDWELLING CATHETER; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; URINARY TRACT INFECTION; BACTERIAL COUNT; BACTERIOLYSIS; CATHETER INFECTION; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; PHYSIOLOGY; VIROLOGY;

BACTERIOLYSIS; BACTERIOPHAGES; BIOFILMS; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; HUMANS; PROTEUS MIRABILIS;

EID: 77954650996     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2010.00696.x     Document Type: Article

References (34)

1. Adams MH (1959) Bacteriophages. John Wiley and Sons Inc.
2. Ahearn DG, Grace DT, Jennings MJ, Borazjani RN, Boles KJ, Rose LJ, Simmons RB Ahanotu EN (2000) Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections. Curr Microbiol 41 : 120 125.
3. Alanis AJ (2005) Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 36 : 697 705.
4. Azeredo J Sutherland IW (2008) The use of phages for the removal of infectious biofilms. Curr Pharm Biotechno 9 : 261 266.
5. Broxmeyer L, Sosnowska D, Miltner E, Chacón O, Wagner D, McGarvey J, Barletta RG Bermudez LE (2002) Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J Infect Dis 186 : 1155 1160.
6. Ceri H, Olson ME, Stremick C, Read RR, Morck D Buret A (1999) The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37 : 1771 1776.
7. Choong S, Wood S, Fry C Whitfield H (2001) Catheter associated urinary tract infection and encrustation. Int J Antimicrob Ag 17 : 305 310.
8. Coker C, Poore CA, Li X Mobley HLT (2000) Pathogenesis of Proteus mirabilis urinary tract infection. Microbes Infect 2 : 1497 1505.
9. Corbin BD, McLean RJC Aron GM (2001) Bacteriophage T4 multiplication in a glucose limited Escherichia coli biofilm. Can J Microbiol 47 : 680 684.
10. Curtin JJ Donlan RM (2006) Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Ch 50 : 1268 1275.
11. Dumanski AJ, Hedelin H, Edin-Liljegren A, Beauchemin D McLean RJ (1994) The ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi. Infect Immun 62 : 2998 3003.
12. Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM Donlan RM (2010) Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Ch 54 : 397 404.
13. Gilmore BF, Jones DS, Gorman SP Ceri H (2009) Models for the assessment of biofilm and encrustation formation on urological materials. Biomaterials and Tissue Engineering in Urology (Denstedt J Atala A, eds), pp. 59 78. CRC Press
14. Gorman SP Tunney MM (1997) Assessment of encrustation behaviour or urinary tract biomaterials. J Biomat Appl 12 : 136 166.
15. Hanlon GW, Denyer SP, Olliff CJ Ibrahim LJ (2001) Reduction of exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl Environ Microb 67 : 2746 2753.
16. Hendrix RW (2002) Bacteriophages: evolution of the majority. Theor Popul Biol 61 : 471 480.
17. Hughes KA, Sutherland IW Jones MV (1998) Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144 : 3039 3047.
18. Johnson JR, Berggren T Conway AJ (1993) Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens. Antimicrob Agents Ch 37 : 2033 2036.
19. Johnson JR, Kuskowski MA Wilt TJ (2006) Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med 144 : 116 126.
20. Jones BD Mobley HL (1987) Genetic and biochemical diversity of ureases of Proteus, Providencia and Morganella species isolated from urinary tract infection. Infect Immun 55 : 2198 2203.
21. Kohler-Ockmore J Feneley RCL (1996) Long-term catheterization of the bladder: prevalence and morbidity. Brit J Urol 77 : 347 351.
22. Lee SJ, Kim SW, Cho YH, Shin WS, Lee SE, Kim CS, Hong SJ, Chung BYH, Kim JJ Yoon MS (2004) A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. Int J Antimicrob Ag 24 : S65 S69.
23. Lu TK Collins JJ (2007) Dispersing biofilms with engineered enzymatic bacteriophage. P Natl Acad Sci USA 104 : 11197 11202.
24. Payne D Tomasz A (2004) The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents. Curr Opin Microbiol 7 : 435 438.
25. Potempa J Travis J (2000) Bacterial proteinases as targets for the development of second-generation antibiotics. Biochim Biophys Acta 1477 : 35 50.
26. Rasmussen TB Givskov M (2006) Quorum sensing inhibitors: a bargain of effects. Microbiology 152 : 895 904.
27. Rozalski A, Sidorczyk Z Kotelko K (1997) Potential virulence factors of Proteus bacilli. Microbiol Mol Biol R 61 : 65 89.
28. Saint S Chenowith CE (2003) Biofilms and catheter-associated urinary tract infections. Infect Dis Clin N Am 17 : 411 432.
29. Stepanovic S, Vukovic D, Dakic I, Savic B Svabic-Vlahovic M (2000) A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Meth 40 : 175 179.
30. Stewart PS Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358 : 135 138.
31. Stickler DJ (1996) Bacterial biofilms and the encrustation of urethral catheters. Biofouling 94 : 293 305.
32. Sulakvelidze A, Alavidze Z Morris JG (2001) Bacteriophage therapy. Antimicrob Agents Ch 45 : 649 659.
33. Von Eiff C Peters G (2003) Pathogenesis and detection of biofilm formation on medical implants. Medical Biofilms: Detection Prevention and Control (Jass J, Surman S Walker J, eds), pp. 51 72. Wiley
34. Weinstein JW, Mazon D, Pantelick E, Reagan-Cirincione P Hierholzer WJJ (1999) A decade of prevalence surveys in tertiary-care centre: trends in nosocomial infection rates, device utilization and patient acuity. Infect Cont Hosp Ep 20 : 543 548.